KYVERNA THERAPEUTICS INC (KYTX) Stock Cash Flow
NASDAQ:KYTX - Nasdaq - US5019761049 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -145.42M | -127.48M | -60.37M | -28.89M | -26.35M | |||
| Depreciation Amortization | 2.15M | 2.13M | 1.71M | 1.05M | 586.00K | |||
| Change In Working Capital | 7.51M | 7.86M | 3.42M | -10.33M | -4.49M | |||
| Interest Paid | 121.00K | 142.00K | 187.00K | 65.00K | 3.00K | |||
| Other non cash items | 2.12M | 3.24M | 2.83M | 2.06M | 8.10M | |||
| OPERATING CASH FLOW | -133.16M | -114.25M | -52.41M | -36.11M | -22.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.67M | -2.21M | -621.00K | -768.00K | -1.29M | |||
| Other Investing Activity | -31.12M | -158.70M | -8.16M | -13.33M | 0.00 | |||
| INVESTING CASH FLOW | -32.32M | -160.90M | -8.79M | -14.10M | -1.29M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.07M | -956.00K | -781.00K | -249.00K | -41.00K | |||
| Stock Issued/Repurchased | 433.00K | 341.43M | 60.55M | 12.13M | 72.56M | |||
| Other Financing Activity | -477.00K | -3.36M | -1.65M | N/A | N/A | |||
| FINANCING CASH FLOW | -1.30M | 337.11M | 58.12M | 11.88M | 72.52M | |||
| CHANGE IN CASH | -166.79M | 61.96M | -3.08M | -38.33M | 49.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -133.16M | -114.25M | -52.41M | -36.11M | -22.16M | |||
| Capital Expenditure | -1.67M | -2.21M | -621.00K | -768.00K | -1.29M | |||
| FREE CASH FLOW | -134.83M | -116.45M | -53.03M | -36.88M | -23.44M | |||
All data in USD